being and becoming in the world
Kings College London [KCL] has received over £800,000 from Janssen for Esketamine research. Professor Allan Young, Vice Dean and Clinical Academic Lead for KCL, features in this Guardian “Exclusive” [from … Continue reading The promotion of ESKETAMINE
GP edition of the BMJ. 26 September 2020.
I recently shared a BMJ report that outlined the approval of Esketamine in Europe: Since sharing this news, the following rapid response by the MHRA [The Medicines and Healthcare products … Continue reading Esketamine: Regulators and a confusing narrative
Last month I shared a BMJ Editorial on Ketamine by Dr Sameer Jauhar and Dr Paul Morrison. Since then there have been a number of published BMJ responses and replies. … Continue reading Ketamine: “lost in translation?”